JackDempseyBurtonMD

PubMed

• 33 citations
  Enhanced expression of CD74 in gastrointestinal cancers and benign tissues.
  David V. Gold, Rhona Stein, Jack Burton, David M. Goldenberg> ;International Journal of Clinical and Experimental Pathology. 2011 Aug 24
• 2 citations
  New agents and approaches to the treatment of B-cell non-Hodgkin lymphoma
  Jack Burton, David M. Goldenberg> ;Expert Opinion on Emerging Drugs. 2010 Nov 24
• A phase I/II trial of fixed-dose docetaxel plus irinotecan and escalating doses of estramustine phosphate for second-line or greater treatment of selected advanced sol...
  Walid Baz, Fadi Nakhl, Raymond El-Soueidi, Frank Forte, Joseph Lowry, Nelly Aoun, Jack Burton> ;Anti-Cancer Drugs. 2009 Jul 1
• 56 citations
  Potential of peroxisome proliferator-activated receptor gamma antagonist compounds as therapeutic agents for a wide range of cancer types.
  Jack Burton, David M. Goldenberg, Rosalyn D. Blumenthal> ;PPAR Research. 2008 Sep 2
• 158 citations
  CD74: A New Candidate Target for the Immunotherapy of B-Cell Neoplasms
  Rhona Stein, M. Jules Mattes, Thomas M. Cardillo, Hans J. Hansen, Chien-Hsing Chang, Jack Burton, Serengulam V. Govindan, David M. Goldenberg> ;Clinical Cancer Research. 2007 Sep 15
• 31 citations
  Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines.
  Jack Burton, Mary E. Castillo, David M. Goldenberg, Rosalyn D. Blumenthal> ;Anti-Cancer Drugs. 2007 Jun 1
• 22 citations
  Radioimmunotherapy of non-Hodgkin's lymphoma: a critical appraisal.
  Robert M. Sharkey, Jack Burton, David M. Goldenberg> ;Expert Review of Clinical Immunology. 2005 May 1
• 37 citations
  A Phase I Trial Combining High-Dose 90Y-Labeled Humanized Anti-CEA Monoclonal Antibody with Doxorubicin and Peripheral Blood Stem Cell Rescue in Advanced Medullary Thy...
  Robert M. Sharkey, George Hajjar, Dion Yeldell, Arnold Brenner, Jack Burton, A. Rubin, David M. Goldenberg> ;Journal of Nuclear Medicine. 2005 Apr 1
• 107 citations
  CD74 is expressed by multiple myeloma and is a promising target for therapy.
  Jack Burton, Scott Ely, Praveen K. Reddy, Rhona Stein, David V. Gold, Thomas M. Cardillo, David M. Goldenberg> ;Clinical Cancer Research. 2004 Oct 1
• 66 citations
  Radioimmunotherapy of Non-Hodgkin’s Lymphoma with 90Y-DOTA Humanized Anti-CD22 IgG (90Y-Epratuzumab): Do Tumor Targeting and Dosimetry Predict Therapeutic Response?
  Robert M. Sharkey, Arnold Brenner, Jack Burton, George Hajjar, Stephen P. Toder, Abass Alavi, Alexander Matthies, Donald E. Tsai, Stephen J. Schuster, Edward A. Stadtm...> ;Journal of Nuclear Medicine. 2003 Dec 1
• 40 citations
  Phase I Radioimmunotherapy Trial with Iodine-131—Labeled Humanized MN-14 Anti—Carcinoembryonic Antigen Monoclonal Antibody in Patients with Metastatic Gastrointestinal...
  George Hajjar, Robert M. Sharkey, Jack Burton, Chu-Hui Zhang, Dion Yeldell, Alexander Matthies, Abass Alavi, Michele J. Losman, Arnold Brenner, David M. Goldenberg> ;Clinical Colorectal Cancer. 2002 May 1
• 175 citations
  Celecoxib Exhibits the Greatest Potency amongst Cyclooxygenase (COX) Inhibitors for Growth Inhibition of COX-2-negative Hematopoietic and Epithelial Cell Lines
  Chris Waskewich, Rosalyn D. Blumenthal, Honglan Li, Rhona Stein, David M. Goldenberg, Jack Burton> ;Cancer Research. 2002 Apr 1
• 45 citations
  Chronotherapy and Chronotoxicity of the Cyclooxygenase-2 Inhibitor, Celecoxib, in Athymic Mice Bearing Human Breast Cancer Xenografts
  Rosalyn D. Blumenthal, Chris Waskewich, David M. Goldenberg, Walter Lew, Christine Flefleh, Jack Burton> ;Clinical Cancer Research. 2001 Oct 1
• 56 citations
  Radionuclides Linked to a CD74 Antibody as Therapeutic Agents for B-Cell Lymphoma: Comparison of Auger Electron Emitters with β-Particle Emitters
  Serengulam V. Govindan, David M. Goldenberg, Sammy Elsamra, Gary L. Griffiths, Gaik Lin Ong, Martin W. Brechbiel, Jack Burton, George Sgouros, M. Jules Mattes> ;Journal of Nuclear Medicine. 2000 Dec 1
• 113 citations
  Identification of a novel receptor/signal transduction pathway for IL‐15/T in mast cells
  Yutaka Tagaya, Jack D. Burton, Yoshihisa Miyamoto, Thomas A. Waldmann> ;The EMBO Journal. 1996 Sep 16
• 179 citations
  Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region /IL-15 fusion me...
  Richard N. Bamford, Andrew P. Battiata, Jack D. Burton, Harmesh Sharma, Thomas A. Waldmann> ;Proceedings of the National Academy of Sciences of the United States of America. 1996 Apr 2
• 42 citations
  Abnormal cytokine expression in Sézary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies.
  C L Tendler, Jack D. Burton, J Jaffe, David Danielpour, M Charley, J P McCoy, Mark R. Pittelkow, Thomas A. Waldmann> ;Cancer Research. 1994 Aug 15
• 337 citations
  The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of l...
  Richard N. Bamford, Angus Grant, Jack D. Burton, Christian J. Peters, Gloria Kurys, Carolyn K. Goldman, J Brennan, Erich Roessler, Thomas A. Waldmann> ;Proceedings of the National Academy of Sciences of the United States of America. 1994 May 24
• 313 citations
  A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokin...
  Jack D. Burton, Richard N. Bamford, Christian J. Peters, Angus Grant, Gloria Kurys, Carolyn K. Goldman, Jennifer Brennan, Erich Roessler, Thomas A. Waldmann> ;Proceedings of the National Academy of Sciences of the United States of America. 1994 May 24
• 5 citations
  The Interleukin‐2 Receptor: A Target for Immunotherapy
  Thomas A. Waldmann, Carolyn K. Goldman, Lois E. Top, Angus Grant, Jack D. Burton, Richard N. Bamford, Erich Roessler, Ivan Horak, Sara Zaknoen, Claude Kasten-Sportes, ...> ;Annals of the New York Academy of Sciences. 1993 Jun 1
• 4 citations
  The interleukin-2 receptor: a target for immunotherapy.
  Thomas A. Waldmann, Carolyn K. Goldman, Lois E. Top, Angus Grant, Jack D. Burton, Richard N. Bamford, Erich Roessler, Ivan D. Horak, Sara Zaknoen, Claude Kasten-Sporte...> ;Advances in Experimental Medicine and Biology. 1992 Jan 1
• 96 citations
  Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
  Craig L. Tendler, Steven J. Greenberg, Jack D. Burton, David Danielpour, Seong-Jin Kim, William A. Blattner, Angela Manns, Thomas A. Waldmann> ;Journal of Cellular Biochemistry. 1991 Aug 1
• 175 citations
  Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications an...
  Craig L. Tendler, Steven J. Greenberg, Blattner Wa, Angela Manns, E Murphy, Thomas A. Fleisher, Barrie Hanchard, Owen St. C. Morgan, Jack D. Burton, David L. Nelson> ;Proceedings of the National Academy of Sciences of the United States of America. 1990 Jul 1
• 193 citations
  Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production...
  Seong-Jin Kim, John H. Kehrl, Jack D. Burton, Craig L. Tendler, Kuan-Teh Jeang, David Danielpour, C. Thevenin, Kyung Young Kim, Michael B. Sporn, Anita B. Roberts> ;The Journal of Experimental Medicine. 1990 Jul 1
• 20 citations
  Human B lymphocytes express the p75 component of the interleukin 2 receptor.
  C. Glenn Begley, Jack D. Burton, Mitsuro Tsudo, Bernard H. Brownstein, Thomas A. Waldmann> ;Leukemia Research. 1990 Jan 1
• Join now to see all